U.S. Water Utilities Stock News

NasdaqGS:TSLA
NasdaqGS:TSLAAuto

3 Growth Companies With High Insider Ownership Seeing Up To 26% Revenue Growth

As the U.S. market navigates a volatile week marked by fluctuating stock futures and record highs in gold prices, investors are increasingly seeking stability amidst uncertainty. In such an environment, growth companies with high insider ownership can present attractive opportunities, as they often demonstrate strong alignment between management and shareholder interests, potentially driving robust revenue growth.
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab Holdings And 2 Promising Penny Stocks For Your Watchlist

As the U.S. stock market navigates a volatile period, marked by fluctuations in major indices and record highs in gold prices, investors are increasingly exploring diverse opportunities to mitigate risks and enhance their portfolios. Penny stocks, though considered a niche area of investment today, continue to offer intriguing possibilities for growth by focusing on smaller or newer companies with potential upside. In this article, we will examine three penny stocks that demonstrate strong...
NYSE:YALA
NYSE:YALAInteractive Media and Services

Undiscovered Gems in the US Market to Watch This January 2026

As the U.S. stock market experiences a rebound with major indices like the Dow and S&P 500 closing higher due to eased geopolitical tensions, investors are keenly observing small-cap stocks for potential opportunities. In this dynamic environment, identifying promising stocks often involves looking for companies that can navigate economic shifts and capitalize on emerging trends, making them potential gems in the current market landscape.
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Is Recursion (RXRX) Turning Nvidia-Backed AI Hype Into a Durable Drug Discovery Advantage?

Recent commentary on Recursion Pharmaceuticals has highlighted its AI-driven drug discovery platform, including the BioHive-2 supercomputer and the Recursion OS, alongside its collaboration with Nvidia and a cash runway that management indicates extends through 2027. Analyst optimism and insider share purchases have reinforced investor attention on Recursion’s attempt to fuse biology, automation, and advanced computing into a differentiated approach to pharmaceutical development. Against...